首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Intensification to biphasic insulin aspart 30/70 (BIAsp 30 NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study

【2h】

Intensification to biphasic insulin aspart 30/70 (BIAsp 30 NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study

机译：加强对双相胰岛素aspart 30/70（BIAsp 30NovoMix®30）可以改善接受基础胰岛素治疗的患者的血糖控制：IMPROVE™观察性研究的亚组分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims:The international IMPROVE™ observational study investigated the safety profile and effectiveness of biphasic insulin aspart 30/70 (BIAsp 30) in the routine treatment of patients with type 2 diabetes. We present analyses for the subgroup of patients who switched from basal insulin to BIAsp 30.

机译：目的：国际IMPROVE™观察性研究调查了双相门冬胰岛素30/70（BIAsp 30）在2型糖尿病患者常规治疗中的安全性和有效性。我们对从基础胰岛素转为BIAsp 30的患者亚组进行了分析。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
J Gumprecht; M Benroubi; V Borzi; R Kawamori; J Shaban; S Shah; M Shestakova; Y Wenying; R Ligthelm; P Valensi;
展开▼
作者单位

展开▼
年(卷),期 -1(63),6
年度 -1
页码 966–972
总页数 7
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study. [J] . Gumprecht J, Benroubi M, Borzi V International journal of clinical practice . 2009,第6期

机译：对基础胰岛素治疗的患者，加强双相胰岛素门冬氨酸30/70（BIAsp 30，NovoMix 30）可以改善血糖控制：IMPROVE观察性研究的亚组分析。
2. Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study. [J] . Shah S, Benroubi M, Borzi V, International journal of clinical practice . 2009,第4期

机译：在2型糖尿病患者中从人预混胰岛素转换时，双相胰岛素aspart 30/70（NovoMix 30）的安全性和有效性：来自为期6个月的IMPROVE观察性研究的亚组分析。
3. Cost-effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp-30) in type 2 diabetes patients with suboptimal glycaemic control in Singapore [J] . SY Goh, SC Tan, LC Lim, Journal of Diabetology: Official Journal of Diabetes in Asia Study Group . 2015,第1期

机译：在新加坡，血糖控制不佳的2型糖尿病患者从双相人胰岛素（BHI）转换为门冬胰岛素30（BIAsp-30）的成本效益
4. Improved 3D Stochastic Modelling of Insulin Sensitivity Variability for Improved Glycaemic Control [C] . Vincent Uyttendaele, J. L. Knopp, G. M. Shaw, IFAC Symposium on Biological and Medical Systems . 2019

机译：改进了胰岛素敏感性变异性改善血糖控制的三维随机造型
5. Conversational Artificial Intelligence and Patient Generated Health Data: Transitional Patient Applications to Improve Outcomes in the 30 Day Post-discharge Window [D] . Mazza, Kathleen . 2020

机译：会话人工智能和患者产生的健康数据：过渡患者应用，以改善30天后排出后窗口的结果
6. Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study [O] . S Shah, M Benroubi, V Borzi, -1

机译：当从人类预混胰岛素转换为2型糖尿病患者时双相胰岛素aspart 30/70（NovoMix®30）的安全性和有效性：为期6个月的IMPROVE™观察性研究的亚组分析
7. Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study [O] . Gumprecht, J, Benroubi, M, Borzi, V, 2009

机译：加强对双相胰岛素aspart 30/70（BIAsp 30，NovoMix®30）可以改善接受基础胰岛素治疗的患者的血糖控制：IMPROVE™观察性研究的亚组分析

Intensification to biphasic insulin aspart 30/70 (BIAsp 30 NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study

摘要

著录项

相似文献

相关主题

期刊订阅